Difference between revisions of "Cancer United"

From SourceWatch
Jump to navigation Jump to search
(SW: sectioning)
m (SW: add categories)
Line 33: Line 33:
 
*David Miller '[http://www.spinwatch.org/content/view/3525/29/ This campaign brought to you by...]' ''Spinwatch'', 29 October 2006.
 
*David Miller '[http://www.spinwatch.org/content/view/3525/29/ This campaign brought to you by...]' ''Spinwatch'', 29 October 2006.
  
[[Category: Health]][[Category: Pharmaceutical industry]][[Category: Europe]][[Category: Pharmaceutical fronts]] [[Category: Cancer]] [[Category: Industry lobby groups]] [[Industry-funded groups]]
+
[[Category: Health]][[Category: Pharmaceutical industry]][[Category: Europe]][[Category: Pharmaceutical fronts]] [[Category: Cancer]] [[Category: Industry lobby groups]] [[Industry-funded organizations]]

Revision as of 16:05, 26 August 2009

{{#badges: Front groups}} Cancer United is a drug company front group established by Weber Shandwick and funded entirely by Roche.

In August 2006, Guardian journalist Sarah Boseley wrote ahead of the group's launch that it "is being presented as a pioneering effort by a coalition of doctors, nurses and patients to push for equal access to cancer care across the EU. However, the campaign is being entirely funded by Roche, the maker of Herceptin and Avastin. A senior company executive sits on the board. The company's PR firm, Weber Shandwick has been heavily promoting the group to clinicians and journalists. The principal study on which the group is based was also funded by Roche Laboratories and has been hotly contested. [1]

Contact Details

Web: http://www.cancerunited.org/

Articles & sources

SourceWatch Resources

References

  1. Sarah Boseley, "Concern over cancer group's link to drug firm", Guardian (UK), October 18, 2006.

External articles